Literature DB >> 22982511

Reactive oxygen species (ROS) and sensitization to TRAIL-induced apoptosis, in Bayesian network modelling of HeLa cell response to LY303511.

Lisa Tucker-Kellogg1, Yuan Shi, Jacob K White, Shazib Pervaiz.   

Abstract

BACKGROUND: The compound LY303511 (LY30) has been proven to induce production of ROS and to sensitize cancer cells to TRAIL-induced apoptosis, but the mechanisms and mediators of LY30-induced effects are potentially complex. Bayesian networks are a modelling technique for making probabilistic inferences about complex networks of uncertain causality.
METHODS: Fluorescent indicators for ROS, reactive nitrogen species (RNS), and free calcium were measured in time-series after LY30 treatment. This "correlative" dataset was used as input for Bayesian modelling to predict the causal dependencies among the measured species. Predictions were compared against a separate "causal" dataset, in which cells had been treated with FeTPPS to scavenge peroxynitrite, EGTA-am to chelate calcium, and Tiron to scavenge O(2)(-). Finally, cell viability measurements were integrated into an extended model of LY30 effects.
RESULTS: LY30 treatment caused a rapid increase of ROS (measured by DCFDA) as well as a significant increase in RNS and calcium. Bayesian modelling predicted that Ca(2+)was a partial cause of the ROS induced by short incubations with LY30, and that RNS was strongly responsible for the ROS induced by long incubations with LY30. Validation experiments confirmed the predicted roles of RNS and calcium, and also demonstrated a causal role for O(2)(-). In cell viability experiments, the additive effects of calcium and peroxynitrite were responsible for 90% of LY30-mediated sensitization to TRAIL-induced apoptosis.
CONCLUSIONS: We conclude that LY30 induces interdependent pathways of reactive species and stress signalling, with peroxynitrite and calcium contributing most significantly to apoptosis sensitization.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22982511     DOI: 10.1016/j.bcp.2012.08.028

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  4 in total

1.  Astaxanthin Sensitizes Low SOD2-Expressing GBM Cell Lines to TRAIL Treatment via Pathway Involving Mitochondrial Membrane Depolarization.

Authors:  Juhyun Shin; Arti Nile; Ramesh Kumar Saini; Jae-Wook Oh
Journal:  Antioxidants (Basel)       Date:  2022-02-13

2.  Synergistic Suppression Effect on Tumor Growth of Colorectal Cancer by Combining Radiotherapy With a TRAIL-Armed Oncolytic Adenovirus.

Authors:  Hangxiang Gao; Xin Zhang; Ying Ding; Rong Qiu; Yupeng Hong; Wanyuan Chen
Journal:  Technol Cancer Res Treat       Date:  2019 Jan-Dec

3.  Identification of a lncRNA based signature for pancreatic cancer survival to predict immune landscape and potential therapeutic drugs.

Authors:  Di Ma; Yuchen Yang; Qiang Cai; Feng Ye; Xiaxing Deng; Baiyong Shen
Journal:  Front Genet       Date:  2022-09-14       Impact factor: 4.772

4.  Curcumin Sensitizes Kidney Cancer Cells to TRAIL-Induced Apoptosis via ROS Mediated Activation of JNK-CHOP Pathway and Upregulation of DR4.

Authors:  Ismael Obaidi; Hilary Cassidy; Verónica Ibáñez Gaspar; Jasmin McCaul; Michael Higgins; Melinda Halász; Alison L Reynolds; Breandan N Kennedy; Tara McMorrow
Journal:  Biology (Basel)       Date:  2020-05-01
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.